Latest analysis of the global PD-1/PD-L1 immunotherapy clinical development pipeline reveals dramatic growth over past two years in number of trials, drug combinations, and drug targets, but lower patient recruitment rates in the U.S. compared to China.
Cancer Research Institute analysis of the global immuno-oncology landscape shows dramatic two-year growth in therapeutic targets and I-O drugs in clinical development
The Cancer Research Institute (CRI), a nonprofit organization dedicated to advancing the discovery and development of powerful immunotherapies for all forms of cancer, has announced the 2019 recipients of its highest scientific and philanthropic awards…
Two nonprofits team up to fund research aimed at discovering and developing immunotherapeutic approaches to treating chordoma, a rare type of bone cancer.
The Cancer Research Institute (CRI) will host its inaugural “Immuno-Oncology: A Future Look” event for healthcare investment analysts and media today in New York City at the New York Academy of Sciences from 10:00 am – 12:00 pm ET.
Five U.S. scientists have been awarded $1.25 million each from the Cancer Research Institute to carry out high-risk, high-reward cancer immunology research with potential to transform cancer treatment
The Cancer Research Institute announced today a series of public education and awareness offerings during its seventh annual Cancer Immunotherapy Month(tm) in June.
The Cancer Research Institute will bestow its highest honors on three scientists who have made fundamental contributions to the fields of immunology and cancer immunotherapy at its annual taking place on Thursday, October 25, 2018, at The Metropolitan …
he Cancer Research Institute will honor biotechnology company Regeneron, and journalist and filmmaker Perri Peltz with the 2018 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research at its annual gala taking place on Thursday, Oc…
Two leading non-profits combine efforts to accelerate cancer immunotherapy clinical trials for patients globally